MedPage Today (8/7) reports, “Methylphenidate (Ritalin) may be a first-choice attention-deficit/hyperactivity disorder” (AD/HD) “medication for kids, while amphetamines may be preferred for adults,” researchers concluded. The findings of the 133-trial meta-analysis were published online Aug. 7 in The Lancet Psychiatry. The authors of an accompanying comment observed, “The results support a moderating effect of age on first-line medication choice, consistent with current use patterns in the USA, with greatest support for methylphenidate in children and adolescents and amphetamine formulations in adults.”
Related Links:
— “The Best ADHD Medication? Meta-Analysis Offers Some Answers, “Kristen Monaco, MedPage Today, August 07, 2018.